CStone Pharmaceuticals' market value is the price at which a share of CStone Pharmaceuticals trades on a public exchange. It measures the collective expectations of CStone Pharmaceuticals investors about its performance. CStone Pharmaceuticals is trading at 0.89 as of the 26th of December 2025. This is a No Change since the beginning of the trading day. The stock's lowest day price was 0.89. With this module, you can estimate the performance of a buy and hold strategy of CStone Pharmaceuticals and determine expected loss or profit from investing in CStone Pharmaceuticals over a given investment horizon. Check out CStone Pharmaceuticals Correlation, CStone Pharmaceuticals Volatility and CStone Pharmaceuticals Alpha and Beta module to complement your research on CStone Pharmaceuticals.
Please note, there is a significant difference between CStone Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if CStone Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CStone Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
CStone Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to CStone Pharmaceuticals' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of CStone Pharmaceuticals.
0.00
11/26/2025
No Change 0.00
0.0
In 30 days
12/26/2025
0.00
If you would invest 0.00 in CStone Pharmaceuticals on November 26, 2025 and sell it all today you would earn a total of 0.00 from holding CStone Pharmaceuticals or generate 0.0% return on investment in CStone Pharmaceuticals over 30 days. CStone Pharmaceuticals is related to or competes with Kuros Biosciences, Mesoblast, Ascletis Pharma, PeptiDream, Pharma Mar, Oxford Nanopore, and China Traditional. CStone Pharmaceuticals, a biopharmaceutical company, researches, develops, and commercializes immuno-oncology and precis... More
CStone Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure CStone Pharmaceuticals' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess CStone Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for CStone Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as CStone Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use CStone Pharmaceuticals historical prices to predict the future CStone Pharmaceuticals' volatility.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as CStone Pharmaceuticals. Your research has to be compared to or analyzed against CStone Pharmaceuticals' peers to derive any actionable benefits. When done correctly, CStone Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in CStone Pharmaceuticals.
CStone Pharmaceuticals Backtested Returns
CStone Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.13, which signifies that the company had a -0.13 % return per unit of risk over the last 3 months. CStone Pharmaceuticals exposes sixteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm CStone Pharmaceuticals' Mean Deviation of 0.4909, standard deviation of 2.44, and Risk Adjusted Performance of 0.0302 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.043, which signifies not very significant fluctuations relative to the market. As returns on the market increase, CStone Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding CStone Pharmaceuticals is expected to be smaller as well. At this point, CStone Pharmaceuticals has a negative expected return of -0.17%. Please make sure to confirm CStone Pharmaceuticals' treynor ratio and rate of daily change , to decide if CStone Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation
0.00
No correlation between past and present
CStone Pharmaceuticals has no correlation between past and present. Overlapping area represents the amount of predictability between CStone Pharmaceuticals time series from 26th of November 2025 to 11th of December 2025 and 11th of December 2025 to 26th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of CStone Pharmaceuticals price movement. The serial correlation of 0.0 indicates that just 0.0% of current CStone Pharmaceuticals price fluctuation can be explain by its past prices.
Correlation Coefficient
0.0
Spearman Rank Test
1.0
Residual Average
0.0
Price Variance
0.0
CStone Pharmaceuticals lagged returns against current returns
Autocorrelation, which is CStone Pharmaceuticals pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting CStone Pharmaceuticals' pink sheet expected returns. We can calculate the autocorrelation of CStone Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that CStone Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values
Timeline
CStone Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If CStone Pharmaceuticals pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if CStone Pharmaceuticals pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in CStone Pharmaceuticals pink sheet over time.
Current vs Lagged Prices
Timeline
CStone Pharmaceuticals Lagged Returns
When evaluating CStone Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of CStone Pharmaceuticals pink sheet have on its future price. CStone Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, CStone Pharmaceuticals autocorrelation shows the relationship between CStone Pharmaceuticals pink sheet current value and its past values and can show if there is a momentum factor associated with investing in CStone Pharmaceuticals.
Other Information on Investing in CStone Pink Sheet
CStone Pharmaceuticals financial ratios help investors to determine whether CStone Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CStone with respect to the benefits of owning CStone Pharmaceuticals security.